Learn More
Medchemexpress LLC Pamufetinib mesylate | 1688673-09-7 | 99.2% | 614.66 | C28H27FN4O7S2 | 10MG

Supplier: Medchemexpress LLC HY12423A10MG
Pamufetinib mesylate is the methanesulfonate (mesylate) salt of pamufetinib (TAS-115), a small-molecule tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) and hepatocyte growth factor receptor (c-Met/HGFR). It exhibits low-nanomolar biochemical potency (IC50 = 30 nM for rVEGFR2; 32 nM for rMET) and is supplied as a high-purity solid for research use.
- Dual inhibition of VEGFR and c-Met with low-nanomolar potency.
- Provided as the mesylate salt to enhance handling and stability.
- High purity (>99.1%) suitable for biochemical and cell assays.
- Soluble in DMSO (~75 mg/mL), enabling preparation of concentrated stocks.
- Storage recommendations include refrigerated, moisture-protected storage; in solvent long-term at -80°C.
- Available in research pack sizes appropriate for in vitro and in vivo studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.